Tonsil injection allergy shots for hay fever
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This trial tests a new way to treat allergies by injecting allergy medicine directly into the tonsils. It may help people with hay fever who haven't gotten relief from standard treatments or want to avoid long-term medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have hay fever with symptoms like sneezing, runny nose, or itchy eyes
- Standard allergy medicines haven't helped enough or you want to stop taking them
- You are between 5 and 65 years old
- You can't avoid the things you're allergic to in daily life
- If you can become pregnant, you must not get pregnant during treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to treat allergic rhinitis (hay fever) caused by dust mites. Instead of allergy shots under the skin or drops under the tongue, the treatment is given as an injection into the tonsils. It aims to reduce allergy symptoms like sneezing and a runny nose.
This trial tests a new way to treat cat allergies by giving tiny injections directly into a lymph node (a part of your immune system), instead of under the skin. It aims to see if this method is safe and can reduce cat allergy symptoms, even in people with asthma.
This study compares two combination treatments for moderate to severe allergic rhinitis (hay fever). One group uses a corticosteroid nasal spray plus an antihistamine nasal spray, and the other uses the same spray plus an oral antihistamine pill. The goal is to see which combination better improves symptoms like sneezing, runny nose, and congestion.
This trial tests a new allergy shot that may reduce symptoms of dust mite allergies, like sneezing, runny nose, and itchy eyes. It might also help with mild asthma caused by dust mites.
This study tests an investigational injection (GR1802) that may help reduce seasonal allergy symptoms when standard allergy medications aren't enough. If you qualify, you'll receive the injection during the pollen season to see if it improves your sneezing, runny nose, and itchy eyes.
This trial tests an experimental antibody (IL4Rα monoclonal antibody) for people with seasonal allergic rhinitis (hay fever) that is not well controlled by standard treatments like nasal steroid sprays. The goal is to see if this new treatment can help reduce allergy symptoms during pollen season.
Hear when a new Allergic Rhinitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.